150 related articles for article (PubMed ID: 35193582)
1. RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma.
Chen Y; Chen X; Pan L; Huang Y; Cai Y; Li J; Li Y; Wang S
Cancer Cell Int; 2022 Feb; 22(1):92. PubMed ID: 35193582
[TBL] [Abstract][Full Text] [Related]
2. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
Zheng W; Wang X; Yu Y; Ji C; Fang L
Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Emodin Derivative on Cell Cycle, Apoptosis and NF-κB Pathway in Burkitt Lymphoma Cells].
Cheng DF; Yang BX; Liu WJ; Qiu CX; Liao JR; Qiu YY; Liu TB; Hu JD; Wang WF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):474-488. PubMed ID: 33812418
[TBL] [Abstract][Full Text] [Related]
4. DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway.
Pan L; Li Y; Zhang HY; Zheng Y; Liu XL; Hu Z; Wang Y; Wang J; Cai YH; Liu Q; Chen WL; Guo Y; Huang YM; Qian F; Jin L; Wang J; Wang SY
Oncotarget; 2017 Oct; 8(52):89643-89654. PubMed ID: 29163777
[TBL] [Abstract][Full Text] [Related]
5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
6. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses.
Mosallanejad K; Sekine Y; Ishikura-Kinoshita S; Kumagai K; Nagano T; Matsuzawa A; Takeda K; Naguro I; Ichijo H
Sci Signal; 2014 Apr; 7(323):ra40. PubMed ID: 24782566
[TBL] [Abstract][Full Text] [Related]
7. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B
BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771
[TBL] [Abstract][Full Text] [Related]
8. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma.
Li Y; Zhang Y; Fu M; Yao Q; Zhuo H; Lu Q; Niu X; Zhang P; Pei Y; Zhang K
Mol Med Rep; 2012 Sep; 6(3):477-82. PubMed ID: 22735892
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway.
Mao S; Jin J; Li Z; Yang W
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33325535
[TBL] [Abstract][Full Text] [Related]
12. RNA helicase DHX15 acts as a tumour suppressor in glioma.
Ito S; Koso H; Sakamoto K; Watanabe S
Br J Cancer; 2017 Oct; 117(9):1349-1359. PubMed ID: 28829764
[TBL] [Abstract][Full Text] [Related]
13. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
[TBL] [Abstract][Full Text] [Related]
14. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
[TBL] [Abstract][Full Text] [Related]
15. Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
Kurokawa M; Ghosh SK; Ramos JC; Mian AM; Toomey NL; Cabral L; Whitby D; Barber GN; Dittmer DP; Harrington WJ
Blood; 2005 Jul; 106(1):235-40. PubMed ID: 15790788
[TBL] [Abstract][Full Text] [Related]
16. The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.
Tong X; Zhang X; Fan J; Tong Y; Li S; Jin J; Yao H
Cancer Biol Ther; 2013 Apr; 14(4):370-7. PubMed ID: 23360784
[TBL] [Abstract][Full Text] [Related]
17. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
[TBL] [Abstract][Full Text] [Related]
18. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
